Susan Marie Milosovich

Title: Susan Marie Milosovich: Innovator in Controlled Release Formulations

Introduction

Susan Marie Milosovich is a notable inventor based in Phoenixville, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. With a total of 2 patents, her work focuses on innovative solutions for treating complex disorders.

Latest Patents

Milosovich's latest patents include a controlled release dosage form of [R-(Z)]-α-(methoxyimino)-α-(1-azabicyclo[2.2.2]oct-3yl) acetonitrile monohydrochloride. This formulation is designed for the treatment and/or prophylaxis of certain disorders. Another significant patent is for a composition aimed at treating dementia and Alzheimer's disease. This controlled release dosage form is useful in enhancing amyloid precursor protein processing along a non-amyloidogenic pathway in patients suffering from, or at risk of developing, Alzheimer's disease.

Career Highlights

Throughout her career, Milosovich has demonstrated a commitment to advancing pharmaceutical science. Her innovative approaches have led to the development of formulations that improve patient outcomes. Her work is characterized by a focus on controlled release mechanisms, which are crucial for effective treatment regimens.

Collaborations

Milosovich has collaborated with esteemed colleagues such as William Thomas Muldoon and Joseph Peter Sauer. These partnerships have fostered a collaborative environment that enhances the research and development of her innovative formulations.

Conclusion

Susan Marie Milosovich stands out as a pioneering inventor in the field of controlled release formulations. Her contributions to the treatment of dementia and Alzheimer's disease highlight her dedication to improving healthcare solutions. Her work continues to inspire advancements in pharmaceutical innovation.